Markets:

Overview

News

Currencies

International

Treasuries

Humacyte, Inc. - Common Stock (NQ:HUMA)

0.7387 +0.0476 (+6.89%)

Streaming Delayed Price Updated: 3:38 PM EDT, Apr 15, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Humacyte, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

May 13, 2025

Via Benzinga

There are notable gap-ups and gap-downs in today's session. ↗

May 13, 2025

Let's delve into the US markets on Tuesday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.

Via Chartmill

Exploring Humacyte's Earnings Expectations ↗

May 12, 2025

Via Benzinga

Small-Caps Explode Higher As Tariff Fears Ease: Humacyte, Forward Air, FormFactor Top Russell 2000 ↗

April 09, 2025

Trump's tariff delay caused the small-cap stocks in iShares Russell 2000 ETF to rise significantly. Semiconductor components were also top performers.

Via Benzinga

Humacyte Earnings Preview ↗

March 27, 2025

Via Benzinga

Earnings Scheduled For May 13, 2025 ↗

May 13, 2025

Via Benzinga

Humacyte Stock Continues Slide Despite Lower Than Expected Q4 Loss – But Retail Gets More Bullish ↗

March 28, 2025

Fourth-quarter loss per share came in at $0.16, lower than the $0.24 in the corresponding period of 2023, and below the consensus estimate of $0.25, according to FinChat data.

Via Stocktwits

Topics Earnings

Earnings Scheduled For March 28, 2025 ↗

March 28, 2025

Via Benzinga

These stocks are moving in today's session ↗

March 26, 2025

Wondering how the US markets performed one hour before the close of the markets on Wednesday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

Keep an eye on the top gainers and losers in Wednesday's session. ↗

March 26, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

March 26, 2025

Via Benzinga

These stocks are gapping in today's session ↗

March 26, 2025

Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Wednesday. Let's explore the market movements and identify the stocks with significant gaps.

Via Chartmill

Why Humacyte (HUMA) Stock Is Falling Sharply ↗

March 26, 2025

Humacyte shares are trading lower by 29% during Wednesday's session. The company priced a $50 million public offering.

Via Benzinga

Top movers in Wednesday's pre-market session ↗

March 26, 2025

The US market session of Wednesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

March 26, 2025

Via Benzinga

Chewy, Bausch Health Companies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

March 26, 2025

Via Benzinga

US Stocks Likely To Open Lower After 3-Day Advance: Market Is Looking 'More Balanced' And Gone From 'Above-Trend To On-Trend,' Says Expert ↗

March 26, 2025

U.S. stock futures were trading lower on Wednesday, after advancing for three consecutive sessions. Futures of major benchmark indices were lower in premarket trading.

Via Benzinga

Why GameStop Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket ↗

March 26, 2025

Via Benzinga

Top movers in Tuesday's after hours session ↗

March 25, 2025

Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

March 25, 2025

Via Benzinga

Humacyte Shares Plunge After Hours: Here's Why ↗

March 25, 2025

Humacyte shares are tumbling in Tuesday's after-hours session after the company announced a proposed public offering.

Via Benzinga

Trestle Bio Announces Research Collaboration with Humacyte

March 06, 2025

From Trestle Biotherapeutics, Inc.

Via Business Wire

HUMACYTE ALERT: Bragar Eagel & Squire, P.C. is Investigating Humacyte, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

January 23, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

HUMA Investors Have Opportunity to Lead Humacyte, Inc. Securities Fraud Lawsuit with the Schall Law Firm

January 17, 2025

From The Schall Law Firm

Via Business Wire

HUMA Deadline: Rosen Law Firm Urges Humacyte, Inc. (NASDAQ: HUMA) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

January 17, 2025

From The Rosen Law Firm, P.A.

Via Business Wire

Faruqi & Faruqi Reminds Humacyte Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 17, 2025 - HUMA

January 17, 2025

From Faruqi & Faruqi LLP

Via GlobeNewswire

HUMA Investors Have Opportunity to Lead Humacyte, Inc. Securities Fraud Lawsuit with the Schall Law Firm

January 16, 2025

From Schall Law

Via GlobeNewswire

Deadline Soon: Humacyte, Inc. (HUMA) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

January 15, 2025

From The Law Offices of Frank R. Cruz

Via Business Wire

HUMA DEADLINE: TOP RANKED ROSEN LAW FIRM Encourages Humacyte, Inc. Investors to Secure Counsel Before Important January 17 Deadline in Securities Class Action - HUMA

January 14, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Wolfspeed, Xerox, Visa, and Humacyte and Encourages Investors to Contact the Firm

January 13, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.